Ontogenetic characteristics of enzyme activities and plasma metabolites in C57BL/6J:Jcl mice deficient in insulin receptor substrate 2

Comparative Medicine

Volumn 56, Issue 3, 2006, Pages 176-187

  Hashimoto, Haruo ^a   Arai, Toshiro ^b   Takeguchi, Akira ^b   Hioki, Kyouji ^a   Ohnishi, Yasuyuki ^a   Kawai, Kenji ^a   Ito, Mamoru ^a   Suzuki, Ryo ^c   Yamauchi, Toshimasa ^c   Ohsugi, Mitsuru ^c   Saito, Muneo ^a   Ueyama, Yoshito ^a,d   Tobe, Kazuyuki ^c   Kadowaki, Takashi ^c   Tamaoki, Norikazu ^a   Kosaka, Kinori ^a,c  

^a CENTRAL INSTITUTE FOR EXPERIMENTAL ANIMALS   (Japan)

^b NIPPON VETERINARY AND LIFE SCIENCE UNIVERSITY   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

^d TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; FATTY ACID; GLUCOSE; INSULIN; INSULIN RECEPTOR SUBSTRATE 2; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHEMICAL ANALYSIS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME DEFICIENCY; ENZYME SUBSTRATE; GENETIC ANALYSIS; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; INBRED STRAIN; INSULIN RELEASE; INSULIN RESISTANCE; LIPID METABOLISM; LIVER CELL; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; ONTOGENY; SKELETAL MUSCLE;

ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; DISEASE MODELS, ANIMAL; GLUCOSE; GLUCOSE TOLERANCE TEST; HYPERGLYCEMIA; INSULIN RESISTANCE; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LIVER; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUSCLE, SKELETAL; PHOSPHOPROTEINS; RECEPTOR, INSULIN;

EID: 33745020642     PISSN: 15320820     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Accili D. 2001. A kinase in the life of the beta cell. J Clin Invest 108:1575-1576.
2. Arai T, Machida Y, Sasaki M, Oki Y. 1989. Hepatic enzyme activities and plasma insulin concentrations in diabetic voles. Vet Res Commun 13:421-426.
3. Araki E, Lipes MA, Patti ME, Bruning JC, Haag BL, Johnson RS, Kahn CR. 1994. Alternative pathway of insulin signaling in mice with targeted disruption of the IRS-1 gene. Nature 372:186-190.
4. Baginski E, Foa PP, Bennie Z. 1974. Glucose-6-phosphatase. In: Bergmeyer HU, editor. Methods of enzymatic analysis, vol 2. New York: Verlag Chemie, p 876-880.
5. Bergmeyer HU, Bernt E. 1964. Malate dehydrogenase. UV-assay. In: Bergmeyer HU, editor. Methods of enzymatic analysis, vol 2. New York: Verlag Chemie, p 613-617.
6. Bergmeyer HU, Gawehn K, Grassl M. 1974. Glucose-6-phosphate dehydrogenase from yeast. In: Bergmeyer HU, editor. Methods of enzymatic analysis, vol 1. New York: Verlag Chemie, p 458-459.
7. Burks DJ, de Mora JF, Schubert M, Withers DJ, Myers MG, Towery HH, Altamuro SL, Flint CL, White MF. 2000. IRS-2 pathways integrate female reproduction and energy homeostasis. Nature 407:377-382.
8. Fukuchi J, Kokontis JM, Hiipakka RA, Chuu CP, Liao S. 2004. Antiproliferative effect of liver X receptor agonists on LNCaP human prostate cancer cells. Cancer Res 64:7686-7689.
9. Gardner LI Jr, Stern MP, Haffner SM, Gaskill SP, Hazuda HP, Relethford JH, Eifler CW. 1984. Prevalence of diabetes in Mexican Americans. Relationship to percent of gene pool derived from Native American sources. Diabetes 33:86-92.
10. Halestrap AP, Denton RM. 1973. Insulin and the regulation of adipose tissue acetyl-coenzyme A caroboxylase. Biochem J 132:509-517.
11. Hess B, Wieker H-J. 1974. Pyruvate kinase from yeast. In: Bergmeyer HU, editor. Methods of enzymatic analysis, vol 2. New York: Academic Press, p 778-783.
12. Huggett AG, Nixon DA. 1957. Use of glucose oxidase, peroxidase and o-dianisidine in determination of blood and urinary glucose. Lancet 2:368-370.
13. Imagawa A, Hanafusa T, Miyagawa J, Matsuzawa Y. 2000. A novel subtype 1 diabetes mellitus characterized by a rapid onset and an absence of diabetes-related antibodies. N Engl J Med 342:301-307.
14. Imagawa A, Hanafusa T, Miyagawa J, Matsuzawa Y. 2000. A proposal of three distinct subtypes of type 1 diabetes mellitus based on clinical and pathological evidence. Ann Med 32:539-543.
15. Jomain-Baum M, Schramm VL, Hanson RW. 1976. Mechanism of 3-mercaptopicolinic acid inhibition of hepatic phosphoenolpyruvate carboxykinase (GTP). J Biol Chem 251:37-44.
16. Kadowaki T. Insights into insulin resistance and type 2 diabetes from knockout mouse models. J Clin Invest 106:459-465.
17. Kahn BB, Flier JS. 2000. Obesity and insulin resistance. J Clin Invest 106:473-481.
18. Kaloustian HD, Stolzenbach FE, Everse J, Kaplan NO. 1969. Lactate dehydrogenase of lobster (Hornarus americanus) tail muscle. I. Physical and chemical properties. J Biol Chem 244:2891-2901.
19. Kido Y, Burks DJ, Withers D, Bruning JC, Kahn CR, White MF, Accili D. 2000. Tissue-specific insulin resistance in mice with mutations in the insulin receptor, IRS-1, and IRS-2. J Clin Invest 105:199-205.
20. King H, Aubert R, Herman W. 1998. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 21:1414-1431.
21. Kubota N, Tobe K, Terauchi Y, Eto K, Yamauchi T, Suzuki R, Tsubamoto Y, Komeda K, Nakano R, Miki H, Satoh S, Sekihara H, Sciacchitano S, Lesniak M, Aizawa S, Nagai R, Kimura S, Akanuma Y, Taylor SI, Kadowaki T. 2000. Disruption of insulin receptor substrate 2 causes type 2 diabetes because of liver insulin resistance and lack of compensatory beta-cell hyperplasia. Diabetes 49:1880-1889.
22. Leiter EH, Beamer WG, Coleman DL, Longcope C. 1987. Androgenic and estrogenic metabolites in serum of mice fed dehydroepiandrosterone: relationship to anti-hyperglycemic effects. Metab Clin Exp 36:863-869.
23. Leiter EH, Chapman HD, Coleman DL. 1989. The influence of genetic background on the expression of mutations at the diabetes locus in the mouse. V. Interaction between the db gene and hepatic sex steroid sulfotransferases correlates with gender-dependent susceptibility to hyperglycemia. Endocrinology 124:912-922.
24. Martin BB, Denton RM. 1970. The intracellular localization of enzymes in white-adipose-tissue fat cells and permeability properties of fat-cell mitochondria. Biochem J 117:861-877.
25. Michael MD, Kulkarni RN, Postic C, Previs SF, Shulman GI, Magnuson MA, Kahn CR. 2000. Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction. Mol Cell 6:87-97.
26. Myers MG Jr, White MF. 1996. Insulin signal transduction and the IRS proteins. Annu Rev Pharmacol Toxicol 36:615-658.
27. Nakayama K, Nagahama H, Minamishima YA, Matsumoto M, Nakamichi I, Kitagawa K, Shirane M, Tsunematsu R, Tsukiyama T, Ishida N, Kitagawa M, Nakayama KI, Hatakeyama S. 2000. Targeted disruption of Skp2 results in accumulation of cyclin E and p27 (Kip1), polyploidy and centrosome overduplication. EMBO J 19:2069-2081.
28. Nakayama K, Nagahama H, Minamishima YA, Miyake S, Ishida N, Hatakeyama S, Kitagawa M, Iemura S, Natsume T, Nakayama KI. 2004. Skp2-mediated degradation of p27 regulates progression into mitosis. Dev Cell 6:661-672.
29. Olefsky JM. 2000. Treatment of insulin resistance with peroxisome proliferator-activated receptor gamma agonists. J Clin Invest 106:467-472.
30. Patti ME, Sun XJ, Bruening JC, Araki E, Lipes MA, White MF, Kahn CR. 1995. 4PS/insulin receptor substrate (IRS)-2 is the alternative substrate of the insulin receptor in IRS-1-deficient mice. J Biol Chem 270:24670-24673.
31. Rej R, Horder M. 1983. Aspartate aminotransferase (glutamate oxaloacetate transaminase). In: Bergmeyer HU, editor. Methods of enzymatic analysis. 3rd ed. New York: Verlag Chemie, p 416-433.
32. Saltiel AR. 2001. New perspectives into the molecular pathogenesis and treatment of type 2 diabetes. Cell 104:517-529.
33. Schmidt E. Glutamate dehydrogenase UV-assay. 1974. In: Bergmeyer HU, editor. Methods of enzymatic analysis, vol 2. New York: Verlag Chemie, p 650-656.
34. Suzuki R, Tobe K, Aoyama M, Inoue A, Sakamoto K, Yamauchi T, Kamon J, Kubota N, Terauchi Y, Yoshimatsu H, Matsuhisa M, Nagasaka S, Ogata H, Tokuyama K, Nagai R, Kadowaki T. 2004. Both insulin signaling defects in the liver and obesity contribute to insulin resistance and cause diabetes in Irs2(-/-) mice. J Biol Chem 279:25039-25049.
35. Suzuki R, Tobe K, Aoyama M, Sakamoto K, Ohsugi M, Kamei N, Nemoto S, Inoue A, Ito Y, Uchida S, Hara K, Yamauchi T, Kubota N, Terauchi Y, Kadowaki T. 2005. Expression of DGAT2 in white adipose tissue is regulated by central leptin action. J Biol Chem 280:3331-3337.
36. Takeda Y, Suzuki F, Inoue H. 1969. ATP citrate lyase (citrate cleavage enzyme). In: Lowenstein JM, editor. Methods in enzymology, vol 13. New York: Academic Press, p 153-160.
37. Tamemoto H, Kadowaki T, Tobe K, Yagi T, Sakura H, Hayakawa T, Terauchi Y, Ueki K, Kaburagi Y, Satoh S, Sekihara H, Yoshioka S, Horikoshi H, Furuta Y, Ikawa Y, Kasuga M, Yazaki Y, Aizawa S. 1994. Insulin resistance and growth in mice lacking insulin receptor substrate-1. Nature 372:182-186.
38. Terauchi Y, Iwamoto K, Tamemoto H, Komeda K, Ishii C, Kanazawa Y, Asanuma N, Aizawa T, Akanuma Y, Yasuda K, Kodama T, Tobe K, Yazaki Y, Kadowaki T. 1997. Development of non-insulin-dependent diabetes mellitus in the double knockout mice with disruption of insulin receptor substrate-1 and beta cell glucokinase genes. Genetic reconstitution of diabetes as a polygenic disease. J Clin Invest 99:861-866.
39. Tobe K, Suzuki R, Aoyama M, Yamauchi T, Kamon J, Kubota N, Terauchi Y, Matsui J, Akanuma Y, Kimura S, Tanaka J, Abe M, Ohsumi J, Nagai R, Kadowaki T. 2001. Increased expression of the sterol regulatory element-binding protein-1 gene in insulin receptor substrate-2 (-/-) mouse liver. J Biol Chem 19:38337-38340.
40. Tobe K, Tamemoto H, Yamauchi T, Aizawa S, Yazaki Y, Kadowaki T. 1995. Identification of a 190-kDa protein as a novel substrate for the insulin receptor kinase functionally similar to insulin receptor substrate-1. J Biol Chem 270:5698-5701.
41. Tsuji A, Torres-Rosado A, Arai T, Le Beau MM, Lemons RS, Chou S-H, Kurachi K. 1991. Hepsin, a cell membrane-associated protease. Characterization, tissue distribution, and gene localization. J Biol Chem 266:16948-16953.
42. Uchida T, Nakamura T, Hashimoto N, Matsuda T, Kotani K, Sakaue H, Kido Y, Hayashi Y, Nakayama KI, White MF, Kasuga M. 2005. Deletion of Cdkn1b ameliorates hyperglycemia by maintaining compensatory hyperinsulinemia in diabetic mice. Nat Med 11:175-182.
43. Vinuela E, Salas M, Sols A. 1963. Glucokinase and hexokinase in liver in relation to glycogen synthesis. J Biol Chem 238:PC1175-PC1177.
44. Withers DJ, Burks DJ, Towery H, Altamuro SL, Flint CL, White MF. 1999. Irs-2 coordinates Igf-1 receptor-mediated beta-cell development and peripheral insulin signalling. Nat Med 23:32-40.
45. Withers DJ, Gutierrez JS, Towery H, Burks DJ, Ren JM, Previs S, Zhang Y, Bernal D, Pons S, Shulman GI, Bonner-Weir S, White MF. 1998. Disruption of IRS-2 causes type 2 diabetes in mice. Nature 391:900-904.
46. Yamauchi T, Tobe K, Tamemoto H, Ueki K, Kaburagi Y, Yamamoto-Honda R, Takahashi Y, Yoshizawa F, Aizawa S, Akanuma Y, Sonenberg N, Yazaki Y, Kadowaki T. 1996. Insulin signaling and insulin actions in the muscles and livers of insulin-resistant insulin receptor substrate 1-deficient mice. Mol Cell Biol 16:3074-3084.
47. Zimmet P. 1997. The challenge of diabetes. In: Fischer E, Moller G, editors. The medical challenge: complex traits. Munich: Piper, p 55-110.
48. Zimmet P. 2000. Globalization, coca-colonization, and the chronic disease epidemic: can the Doomsday scenario be averted? J Intern Med 247:301-310.
49. Zimmet P, Alberti K, Shaw J. 2001. Global and societal implications of the diabetes epidemic. Nature 414:782-787.